Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
31,500
Employees31,500
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
31,500
Employees31,500

AMGN Key Statistics

Market cap
204.36B
Market cap204.36B
Price-Earnings ratio
26.50
Price-Earnings ratio26.50
Dividend yield
2.56%
Dividend yield2.56%
Average volume
2.68M
Average volume2.68M
High today
$380.09
High today$380.09
Low today
$370.82
Low today$370.82
Open price
$380.00
Open price$380.00
Volume
1.96M
Volume1.96M
52 Week high
$391.29
52 Week high$391.29
52 Week low
$261.43
52 Week low$261.43

Stock Snapshot

Amgen(AMGN) stock is priced at $379.27, giving the company a market capitalization of 204.36B. It carries a P/E multiple of 26.50 and pays a dividend yield of 2.6%.

As of 2026-03-05, Amgen(AMGN) stock has fluctuated between $370.82 and $380.09. The current price stands at $379.27, placing the stock +2.3% above today's low and -0.2% off the high.

Amgen(AMGN) shares are trading with a volume of 1.96M, against a daily average of 2.68M.

During the past year, Amgen(AMGN) stock moved between $261.43 at its lowest and $391.29 at its peak.

During the past year, Amgen(AMGN) stock moved between $261.43 at its lowest and $391.29 at its peak.

AMGN News

TipRanks 15h
Amgen Advances Blinatumomab Franchise With New Phase 3 Subcutaneous Trial

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has filed an update for a new Phase 3 trial titled “A Phase 3, Open-lab...

Nasdaq 2d
Dow Analyst Moves: AMGN

The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Amgen is the #21...

Dow Analyst Moves: AMGN
TipRanks 3d
Amgen’s Phase 3 Gout Trial Pits Subcutaneous Pegloticase Against IV Dosing

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools f...

Analyst ratings

51%

of 37 ratings
Buy
40.5%
Hold
51.4%
Sell
8.1%

More AMGN News

Yahoo Finance 4d
How Amgen’s $4 Billion Long-Dated Bond Issuance At Amgen Has Changed Its Investment Story - Yahoo Finance

...

How Amgen’s $4 Billion Long-Dated Bond Issuance At Amgen Has Changed Its Investment Story - Yahoo Finance
Simply Wall St 4d
Amgen Recasts Growth Story With Product Momentum And Long Dated Funding

Amgen signalled a shift in focus toward growth leadership, backed by strong momentum from products such as Repatha. The company recently guided revenue higher...

Amgen Recasts Growth Story With Product Momentum And Long Dated Funding
TipRanks 6d
Amgen Advances Maridebart Cafraglutide Toward Mid-Stage Obesity and Liver Fat Trial

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is preparing a new Phase 2b trial called “Phase 2b Randomized, Double-b...

TipRanks 6d
Amgen Nears a Nivolumab Biosimilar Milestone in Melanoma: What Investors Should Watch

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Amgen’s Phase 3 study “A Randomized, Double-blind Study Evaluating Pharmacokinetic Simila...

24/7 Wall St. 7d
Got $10,000? Put It in These Dividend Stocks Now

Got $10,000? Put It in These Dividend Stocks Now Quick Read Energy Transfer LP (ET) is an oil and gas pipeline provider that pays a gigantic 7%+ dividend. Amg...

Got $10,000? Put It in These Dividend Stocks Now

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.